Results 31 to 40 of about 1,890 (188)

Case Report: CytoSorb hemoadsorption as an adjunctive therapy in critically ill pregnant women with COVID-19 and acute kidney injury—a case series [PDF]

open access: yesFrontiers in Medicine
PurposeCritically ill pregnant women with COVID-19 are at high risk for acute kidney injury (AKI) and a hyperinflammatory state, contributing to multiorgan failure.
Minoo Heidari Almasi   +5 more
doaj   +2 more sources

The Effects of CytoSorb in Critically Ill Adult Patients on Vasopressor Support: A Systematic Review and Meta-Analysis [PDF]

open access: yesLife
Background: The impact of CytoSorb hemoadsorption on hemodynamic stability, mortality, and intensive care unit length of stay in critically ill adult patients requiring vasopressor support is unclear.
Martina Giacco   +4 more
doaj   +2 more sources

Early CytoSorb Hemoadsorption in a Neutropenic Acute Myeloid Leukemia Patient with Carbapenem-Resistant Pseudomonas Septic Shock and ARDS [PDF]

open access: yesDiseases
Neutropenic patients with acute myeloid leukemia (AML) are at high risk for severe, multidrug-resistant infections. Sepsis due to carbapenem-resistant Pseudomonas aeruginosa (CRPA) in this population often leads to septic shock and acute respiratory ...
Wei-Hung Chang, Ting-Yu Hu, Li-Kuo Kuo
doaj   +2 more sources

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T-Cell Immunotherapy for B-Cell Malignancies: A Case Series. [PDF]

open access: yesHematol Oncol
Hematological Oncology, Volume 44, Issue 4, July 2026.
Cavallaro G   +12 more
europepmc   +2 more sources

Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma. [PDF]

open access: yesJ Clin Apher
ABSTRACT The objective of this in vitro experimental was to determine the utility of hemoadsorption (HA) using the CytoSorb adsorber to remove meloxicam and diclofenac from porcine plasma. For this purpose 12 1‐L aliquots of porcine plasma, 6 units were spiked with 293 μg/mL (262–320 μg/mL) diclofenac and 6 with 42.8 μg/mL (41.4–44.7 μg/mL) meloxicam ...
Giani B   +3 more
europepmc   +2 more sources

COVID-19: Hyperinflammatory Syndrome and Hemoadsorption with CytoSorb [PDF]

open access: yesBlood Purification, 2020
Following the emergence of a novel coronavirus from Wuhan, China, the world faced a major problem, so many countries were shocked by the outbreak of this virus. Unlike the rest of its dangerous family, it has a higher reproductive number than Middle East respiratory syndrome, which is estimated to be approximately 3.28 with a median of 2.79 and IQR of ...
Behnam, Masmouei   +3 more
openaire   +2 more sources

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy

open access: yesCritical Care Explorations, 2022
OBJECTIVE:. The CytoSorb hemoadsorption device (CytoSorbents Inc, Monmouth Junction, NJ) is increasingly used in many critical disease states. The potential impact on the pharmacokinetic (PK) of concomitantly administered drugs must be considered in ...
Joerg Scheier, MD   +6 more
doaj   +1 more source

A case report to highlight the impact of extracorporeal cytokine elimination therapy in viper snakebite induced septic shock with acute kidney injury [PDF]

open access: yesInternational Journal of Medical Device and Adjuvant Treatments, 2020
Introduction: Snakebite envenomation can lead to prolonged disruption of hemostasis, neuromuscular paralysis, myolysis (muscle degeneration) followed by release of damage associated molecular patterns, acute kidney injury and hypovolaemic shock due to ...
K. Parikh   +5 more
doaj   +1 more source

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption [PDF]

open access: yesScientific Reports, 2021
Abstract Cytokine hemoadsorption might be beneficial in patients with sepsis. However, its effect on anti-infective agents' disposition remains largely unknown. We sought to determine the influence of hemoadsorption on the pharmacokinetics of common anti-infective agents.
Schneider, A.G.   +6 more
openaire   +5 more sources

Feasibility and Safety of Cytosorb Application in Patients With Acute Liver Failure. [PDF]

open access: yesLiver Int
ABSTRACT Background and Aims Acute liver failure (ALF) is a rare, life‐threatening condition with high mortality and limited therapeutic options beyond liver transplantation. Cytosorb adsorber can be easily applied to continuous renal replacement therapy (CRRT) and potentially support liver function by removing bilirubin and cytokines.
Haselwanter P   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy